This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $73.53 in the latest trading session, marking a -0.65% move from the prior day.
Why CVS Health (CVS) Could Beat Earnings Estimates Again
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights: UnitedHealth, CVS Health, Morgan Stanley, Charles Schwab and Uber Technologies
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, CVS Health, Morgan Stanley, Charles Schwab and Uber Technologies
CVS Health's Selling Seasons Strong, Omnicare Arm Upsets
by Zacks Equity Research
CVS Health's (CVS) 2020 PBM selling season remains strong with gross new business and net new business wins.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $72.76, marking a +0.9% move from the previous day.
Top Research Reports for UnitedHealth, CVS & Morgan Stanley
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group (UNH), CVS Health (CVS) and Morgan Stanley (MS).
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $73.86, moving +0.39% from the previous trading session.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $74.29, marking a +0.8% move from the previous day.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $74.51, marking a +0.17% move from the previous day.
Rite Aid (RAD) Earnings Surpass Estimates in Q3, Stock Up
by Zacks Equity Research
Rite Aid (RAD) posts robust results in third-quarter fiscal 2020. Notably, the bottom line benefits from higher adjusted EBITDA in the quarter.
Walgreens is the Worst Dow Stock Now, Will 2020 Be Different?
by Zacks Equity Research
Despite the dismal performance in recent times, Walgreens (WBA) has chances to bounce back in 2020.
HMO Industry Outlook: Multiple Levers to Drive Growth
by Sapna Bagaria
Aging U.S population, consolidation, use of technology and growing health service businesses provide ample scope for the industry to grow.
CVS Health Rides on Aetna Prospects, Strong Selling Season
by Zacks Equity Research
CVS Health's (CVS) 2020 PBM selling season is approaching closure and the 2021 selling season is ongoing.
The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman
UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services
by Sapna Bagaria
UnitedHealth (UNH) inks an agreement to acquire Diplomat to expand its in-house pharmacy benefit management business.
Top Stock Reports for Toyota, CVS Health & 3M
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor (TM), CVS Health (CVS) and 3M (MMM).
Why Is CVS Health (CVS) Up 3.8% Since Last Earnings Report?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Molina Healthcare Wins Kentucky Medicaid Managed Care Deal
by Zacks Equity Research
Molina Healthcare's (MOH) Kentucky Medicaid Managed Care contract win to aid 2020 premium revenues.
Centene (CNC) Divests IlliniCare as Part of Merger Agreement
by Zacks Equity Research
Centene (CNC) inks a deal to divest IlliniCare to CVS Health to facilitate the pre-announced merger agreement.
CVS Health Set to Acquire Centene's IlliniCare Health Plan
by Zacks Equity Research
CVS Health's (CVS) latest collaboration with Centene is set to expand its Medicaid and Medicare Advantage presence in Illinois.
3 Healthcare Stocks to Counter Tech Encroachment
by Sreyoshi Mukherjee
Traditional U.S. healthcare companies are resorting to vertical integration to counter the tech threat.
The Extreme Risks of Trading Your Own Retirement Assets - November 15, 2019
by Zacks Equity Research
From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.
3 REITs for Dividend Investors to Buy with Stock Market at New Highs
by Benjamin Rains
Here are three highly-ranked REITs we found using our Zacks Stock Screener that dividend investors might want to buy with stock indexes at new highs...
Here's Why You Should Hold on to CVS Health (CVS) For Now
by Zacks Equity Research
Investors can still hold on to CVS Health (CVS) stock, thanks to its solid prospects.
Walgreens Boots Rallies on KKR's Bid but Market View Mixed
by Urmimala Biswas
Albeit the market sentiment is bullish on Walgreens Boots' (WBA) potential acquisition deal, many analysts are in doubt about the company's effective approach to get privatized.